Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,880
+$47 QoQ
Shares Held
12
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,592
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Winch Advisory Services, LLC holds $1,689,136 across 12 Drug Manufacturers - General names. NVS ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,243 | $823,624 | |
| 2 | PFE |
Pfizer Inc
|
17,345 | $417,667 | |
| 3 | ABBV |
AbbVie Inc.
|
692 | $174,134 | |
| 4 | LLY |
ELI LILLY & Co
|
105 | $125,940 | |
| 5 | MRK |
Merck & Co., Inc.
|
453 | $58,210 | |
| 6 | GSK |
GSK plc
|
652 | $34,177 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
213 | $26,910 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
311 | $17,919 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,880 | 12 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,833 | 12 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,516 | 11 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,410 | 11 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,331 | 11 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,226 | 11 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,070 | 11 | Shares | Sole | 2025-01-14 | |
| No filing history on record for this holder in this stock. | ||||||